Skin
Tapinarof (topical)
Aryl Hydrocarbon Receptor Agonist
Other names: Vtama
FAA guidance
Acceptable in the FAA document cited.
The FAA's MedGuide lists tapinarof (topical) (Vtama) as allowed, for psoriasis, with no wait after the first dose, after later doses or after the final dose, used as prescribed.
Track your medicationsMore detail: tapinarof (topical)The rest of Crosscheck's reading, in plain wordsOpen
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
Show the FAA's words: tapinarof (topical)The official FAA wording: three passages, each with its document and dateOpen
Generic: tapinarof (topical)
Brand Name: Vtama
Drug Class: Aryl Hydrocarbon Receptor Agonist
Underlying Condition: Psoriasis
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.